HIV seroprevalence and associated risk factors among male inmates at the Belize Central Prison

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 25, Issue 4, 2009, Pages 292-299

  Gough, Ethan ^a,b   Edwards, Paul ^a,b  

^a Belize Central Prison   (Belize)

^b Ministry of Health   (Belize)

Author keywords

Acquired immunodeficiency syndrome; Belize; HIV seroprevalence; Prisons

Indexed keywords

ANTIBODY; DISEASE PREVALENCE; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MULTIVARIATE ANALYSIS; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; RISK FACTOR; SEXUAL BEHAVIOR;

BELIZE [CENTRAL AMERICA]; CENTRAL AMERICA;

EID: 67949097120     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892009000400002     Document Type: Article

References (41)

1. United Nations Joint Program on HIV/AIDS, World Health Organization. AIDS Epidemic Update. Geneva: UNAIDS; 2004.
2. Calleja JMG, Walker N, Cuchi P, Lazzari S, Ghvs PD, Zacarias F. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS. 2002;16(suppl 3):S3-12.
3. World Bank. HIV/AIDS in Central America: an overview of the epidemic and priorities for prevention. Washington: World Bank; 2003.
4. Ministry of Health, Belize. Annual HIV/ AIDS Epidemiologic Profile: Belize, Central America 2003. Belmopan: Ministry of Health, Epidemiology Unit; 2004.
5. Strazza L, Azevedo RS, Carvalho HB, Massad E. The vulnerability of Brazilian female prisoners to HIV infection. Braz J Med Biol Res. 2004;(37):771-6.
6. Long J, Allwright S, Barry J, Reynolds SR, Thornton L, Bradley F, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ. 2001; (323):1209-14.
7. Wu HZ, Baillargeon J, Grady IT, Black SA, Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas Correctional System. Ann Epidemiol. 2001;(11): 342-6.
8. Allwright S, Bradley F, Long J, Barry J, Thornton Lelia, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000;(321):78-82.
9. Singh S, Prasad R, Mohanty A. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Int J STD AIDS. 1999; (10):475-8.
10. Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A, Tassopoulos P, et al. A survey of bloodborne viruses and associated risk behaviors in Greek prisons. Addiction. 1998;(93): 243-51.
11. Toussaint Togbe Y, Aguirre M, Dedy S, Cobbers D, Kouame B, Traore L, et al. Determinants of HIV transmission in incarcerated populations in Africa: the Cote d'lvoire experience [Abstract]. Int Conf AIDS; 1998 Jun 28-Jul 3;12:1180. (Abstract no. 60986).
12. Rotily M, Galinier-Pujol A, Obadia Y, Moatti JP, Toubiana P, Vernay-Vaisse, et al. HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS.1994;(8):1341.
13. Bird AG, Gore SM, Jolliffe DW, Burns SM. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS. 1992;(6):725-33.
14. Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, et al. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA. 1991;0:1129-32.
15. Christensen PB, Krarup HB, Niesters HG, Norder H, Georgsen J. Prevalence and incidence of blood borne viral infections among Danish prisoners. Eur J Epidemiol. 2000;(16): 1043-9.
16. Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, et al. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission. Eur J Epidemiol. 1999;(15):439-45.
17. Thaisri H, Leritworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, et al. HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis. 2003;(3):25.
18. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;(94): 1218-23.
19. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003;(326):308-12.
20. Maruschak LM. HIV in prisons and jail. In: Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs and who is at risk. AIDS Educ Prev. 2002;14(suppl B):53-64.
21. World Health Organization. HIV in prisons: a reader with particular relevance to the newly independent states. WHO Regional Office for Europe; 2001.
22. Hutchinson SJ, Gore SM, Goldberg DJ, Yirrel DL, McGregor J, Bird AG, et al. Method used to identify previously undiagnosed infections in the HIV outbreak in Glenochil prison. Epidemiol Infect.l999;(123):271-5.
23. Yirrell DJ, Hutchinson SJ, Griffin M, Gore SM, Leigh-Brown AJ, Goldberg DJ. Completing the molecular investigation into the HIV outbreak at Glenochil prison. Epidemiol Infect. 1999;(123):277-82.
24. Yirrell DL, Robertson P, Goldberg DJ, Mc-Menamin J, Cameron S, Leigh Brown AJ. Molecular investigation into outbreak of HIV in a Scottish prison. BMJ. 1997;(314):1446-50.
25. Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, Cameron S, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;(310): 289-92.
26. Dolan K, Wodak A, Dwyer D, Saksena N. Epidemiological and genetic evidence for HIV transmission in an Australian prison system. In: Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug Alcohol Depend. 1998;(50): 197-202.
27. Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs and who is at risk. AIDS Educ Prev. 2002;14(suppl B):53-64.
28. Castro K, Shansky R, Scardino V, Narkunas J, Coe J, Hammett T. HIV transmission in correctional facilities [Abstract]. Seventh International Conference on AIDS 1991; Florence (Abstract No MC 3067, p 314).
29. Horsburgh CR Jr, Jarvis JQ, McArther T, Ignacio T, Stock P. Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health.l990;(80):209-10.
30. Brewer TF, Vlahov D, Taylor E, Hall D, Munoz A, Polk BF. Transmission of HIV-1 within a statewide prison system. AIDS. 1988;(2):363-7.
31. McKenna SL, Muyinda GK, Roth D, Mwali M, Ng'andu N, Myrick A, et al. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS. 1997;ll(suppl 1):S103-10.
32. Central Statistical Office. Living standard measurement survey: coder's manual. Belize: CSO; 2002.
33. Wolfe MI, Xu F, Patel P, O'Cain M, Schillinger JA, St Louis ME, et al. An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. Am J Public Health. 2001;(91):1220-5.
34. Centers for Disease Control and Prevention. Hepatitis B outbreak in a state correctional facility, 2000. MMWR Morb Mortal Wkly Rep. 2001;(50):529-32.
35. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan, TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002;(35): 305-12.
36. Beyrer C, Jittiwutikarn J, Teokul W, Razak MH, Suriyanon V, Srirak N, et al. Drug use, increasing incarceration rates and prisonassociated HIV risk in Thailand. AIDS Behav. 2003;(7):153-61.
37. Entz AT, Ruffolo VP, Chinveschakitvanich V, Soskolne V, van Griensven GJ. HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea. AIDS. 2000;(14):1027-34.
38. Silverman AL, Sekhon JS, Saginaw SJ, Wiedbrauk D, Balasubramaniam M, Gordon SC. Tattoo application is not associated with an increased risk for chronic viral hepatitis. Am J Gastroenterol. 2000;(95):1312-5.
39. Balasekaran R, Bulterys M, Jamal MM, Quinn PG, Johnston DE, Skipper B, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol. 1999;(94):1341-6.
40. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;(280):42-8.
41. Sabin KM, Frey RL, Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998. J Urban Health. 2001;(78):214-55.